only in pulmonary damage but also to multi-systemic impairment with repercussions on skeletal muscles and the ability to undertake effort. Pulmonologist using the guidelines of diagnosis and classification criteria in GOLD 2014 which used six minutes walking test, body mass index, the degree of obstruction and the risk of exacerbation. However, the assessment of patients with COPD in early stage is very difficult because of physical limitations, the degree of obstruction and the functional capacity to its current status only slightly below normal. In addition, the advanced stages of COPD patients also have many other co-morbid. Most of them is cardiovascular disease which can affects the measurement of several parameters Methods: Cross-sectional study Results: Analysis of 30 patients tested with four parameters were cross sectional study (a: 0.05) with various analysis shows there is a correlation between inspiratory capacity (P < 0.001), six minutes walking test (P < 0.002), body mass index (P < 0.012) and the severity of COPD in a negative prognostic value. There was no correlation between resting heart rate and the severity of COPD Conclusion: Six minutes walking test, inspiratory capacity and the body mass index were correlated with severity of COPD. Parameters that have the strongest correlation with the severity of COPD is inspiratory capacity. Background and Aims: Our previous study showed that perforin regulatory elements were hypomethylated in T cells from rats with autoimmune emphysema. This study aimed at investigating the protective effects of S-adenosylmethionine (SAM), methyl donor in the development of autoimmune emphysema.
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Background and Aims: Our previous study showed that perforin regulatory elements were hypomethylated in T cells from rats with autoimmune emphysema. This study aimed at investigating the protective effects of S-adenosylmethionine (SAM), methyl donor in the development of autoimmune emphysema.
Methods: Thirty SD rats were randomly divided into three groups:normal control group (n = 10), autoimmune emphysema group (model group, n = 10) and SAM intervention group (intervention group, n = 10). The autoimmune emphysema group was treated with intraperitoneal injection of human umbilical vein endothelial cells plus complete Freund's adjuvant. SAM intervention group was treated with intraperitoneal injection of human umbilical vein endothelial cells, complete Freund's adjuvant and SAM, while the normal control group only with equal volume of liquid and complete Freund's adjuvant. Twenty-one days later, the lung tissue sections were stained with haematoxylin and eosin (HE) to observe the morphological changes. Mean liner interval (MLI) and mean alveolar number (MAN) were quantitatively measured .The left lung was subjected to alveolar lavage to prepare BALF. The levels of mean methylation of perforin regulatory elements in T cells ,TNF-α, IL-8, MMP-9, anti-vascular endothelial cell antibody (AECA), Malondialdehyde Content (MDA), superoxide dismutase (SOD), activities of glutathione catalase (GSH-Px), and the glutathione (GSH) were investigated.
Results: The MLI in model group was higher than that in normal control group, while MAN was decreased (all P < 0.05).Compared with model group, MLI in intervention group was decreased, MAN increased (all P < 0.05). The levels of TNF-α, AECA and MAD in BALF in intervention group were lower than those in model group while GSH, SOD, GSH-Px were higher on the contrary (all P < 0.05).
Conclusion: SAM may protects against autoimmune emphysema of rats by increasing levels of perforin regulatory elements methylation in T cells and GSH, SOD, and GSH-Px and decreasing the levels of TNF-α , AECA and MAD. (AECOPD) is an important event that threatens patient quality of life and worsens prognosis. We aimed to investigate the characteristics of COPD patients and risk factors for AECOPD.
Methods:
We retrospectively analyzed COPD patients who visited our hospital from 2014 to 2016. AECOPD was defined as an episode requiring treatment with oral corticosteroid and/or antibiotics, or a visit to the emergency room, or hospitalization. Conclusion: These results suggested that having an episode of AECOPD within the past year, severe airflow limitation, using inhaled corticosteroids or oral glucocorticoids and the presence of bronchial asthma may be risk factors for AECOPD. Prevention of exacerbations and appropriate treatment are highly desirable for patients with these risk factors. Background and Aims: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality. The DECAF score, consisting of the dyspnea score, eosinopenia, consolidation, acidemia and atrial fibrillation, is a simple clinical prediction tool that can stratify patients hospitalized with acute exacerbation of COPD (AECOPD) into clinically relevant risk categories. This study aims to determine the prognostic value of the DECAF score in predicting mortality among patients with AECOPD at the Chinese General Hospital and Medical Center.
Methods: This is a prospective cohort study among COPD in exacerbation patients admitted at Chinese General Hospital. Laboratory and imaging test included complete blood count, chest X-ray, arterial blood gas, and ECG. Stable-state dyspnea was assessed using the extended Medical Research Council Dyspnoea (eMRCD) Score. The DECAF Score were recorded on admission and risk stratification was done following the scoring system. Performance of the tool was assessed by measuring the area under the ROC curve (AUROC). A 95% confidence level was considered significant. Table 1 . Patients with phenotype C and D had poorer modified medical research center (MMRC) performance status and global initiative for COPD (GOLD) class based on FEV1. Nevertheless, only patients with phenotype D had significant higher total SGRQ-c score than others. They also scored significant higher in sub-components of COPD symptoms, activities and impacts. Patients with phenotypes B had numerically higher SGRQ-c total and symptoms score than those with phenotype A and C. The total and sub-components SGRQ-c score of patients with phenotype A and C were almost similar.
Conclusion:
Patients with phenotype D had poorest QOL, followed by phenotype B. These groups of patients need additional medical attention, in terms of pharmacology treatment, physiotherapy and rehabilitation. Background and Aims: The present study was initiated to explore the effect of Bufei Yishen granules (BY) against alveolar epithelial apoptosis via regulating by PERK/eIF2α signalling in chronic obstructive pulmonary disease (COPD) rat model.
Methods:
Rats were randomized into Control, Model, BY, and aminophylline (APL) groups. COPD rats were induced by cigarette-smoke and bacterial exposures (weeks 1-8), and were administrated with normal saline, BY granules or aminophylline from week 9 to 16. Pulmonary function (VT, PEF) was measured every 4 weeks. Lung tissue histology and ultrastructure, alveolar epithelial apoptosis index, PERK, eIF2α, bcl-2 and Bad mRNA as well as protein expressions of PERK, eIF2α, p-PERK, peIF2α in lung tissues were measured.
Results: VT, PEF decreased from week 8 in COPD rats (P < 0.05).
Compared with Model group, VT, PEF were higher in BY groups at week 16, while only VT was higher in APL group (P < 0.05). Markedly histological and ultrastructural changes, including thickened respiratory membrane, vacuolar lamellar corpuscle and reduced mitochondria, were found in COPD rats and were alleviated in the treated groups, especially in BY group. The epithelial apoptosis index significantly increased in COPD rats (P < 0.01), and it decreased in BY and APL groups, while that in BY group was lower than in APL group (P < 0.01). PERK, eIF2α, Bad mRNA increased and Bcl-2 mRNA decreased in COPD rats. PERK, eIF2α and Bad mRNA decreased in BY group (P < 0.05). PERK and Bad mRNA in BY group was lower than that in APL group (P < 0.05). The protein expression of PERK, eIF2α, p-PERK, p-eIF2α increased in Model group (P < 0.01). PERK, p-PERK, p-eIF2α expression in BY group and p-eIF2α APL group decreased compared with Model group (P < 0.05).
